CADTH recommends that general public drug programs reimburse Hemgenix with the remedy of hemophilia B if specified conditions are fulfilled.As for all medicines, knowledge on the use of Hemgenix are continuously monitored. Suspected Negative effects documented with Hemgenix are cautiously evaluated and any necessary motion taken to guard sufferers.